Strategies for achieving high-energy-density lithium-ion batteries include using high-capacity materials such as high-nickel NCM,increasing the active material content in the electrode by utilizing high-conductivity c...Strategies for achieving high-energy-density lithium-ion batteries include using high-capacity materials such as high-nickel NCM,increasing the active material content in the electrode by utilizing high-conductivity carbon nanotubes(CNT)conductive materials,and electrode thickening.However,these methods are still limited due to the limitation in the capacity of high-nickel NCM,aggregation of CNT conductive materials,and nonuniform material distribution of thick-film electrodes,which ultimately damage the mechanical and electrical integrity of the electrode,leading to a decrease in electrochemical performance.Here,we present an integrated binder-CNT composite dispersion solution to realize a high-solids-content(>77 wt%)slurry for high-mass-loading electrodes and to mitigate the migration of binder and conductive additives.Indeed,the approach reduces solvent usage by approximately 30%and ensures uniform conductive additive-binder domain distribution during electrode manufacturing,resulting in improved coating quality and adhesive strength for high-mass-loading electrodes(>12 mAh cm−2).In terms of various electrode properties,the presented electrode showed low resistance and excellent electrochemical properties despite the low CNT contents of 0.6 wt%compared to the pristine-applied electrode with 0.85 wt%CNT contents.Moreover,our strategy enables faster drying,which increases the coating speed,thereby offering potential energy savings and supporting carbon neutrality in wet-based electrode manufacturing processes.展开更多
Antisense oligonucleotides offer a powerful strategy for suppressing pro-inflammatory microRNAs,but efficient long-term delivery after systemic administration remains challenging.In this study,we developed a self-asse...Antisense oligonucleotides offer a powerful strategy for suppressing pro-inflammatory microRNAs,but efficient long-term delivery after systemic administration remains challenging.In this study,we developed a self-assembling oligoDNA-nanomicelle(ODmicelle)platform to simultaneously deliver antisense oligoDNA targeting miR-155 and curcumin,a hydrophobic anti-inflammatory agent,to the lung.The curcumin formulation(OD-micelle/Cur)can be administered intravenously and has a negatively charged surface and average particle size of∼160 nm,supporting scavenger receptor(SR)-mediated pulmonary delivery.Fluorescence imaging and flow cytometry analyses demonstrated that cellular uptake was comparable to that of OD-micelle/PEI25k,a widely used cationic carrier standard.Hemocompatibility tests demonstrated reduced red blood cell aggregation,compared with PEI25k,indicating improved hemocompatibility without compromising delivery efficiency.Mechanistic studies supported the receptor-dependent transport of the oligoDNA corona.Pre-treatment with excess oligonucleotides reduced the cellular uptake and in vivo lung accumulation of Cy5-labeled OD-micelle/Cur.Furthermore,a RAGE antagonist peptide similarly reduced cellular uptake,suggesting the involvement of RAGE in the SR pathway.In LPS-induced acute lung injury(ALI)mice and LPSstimulated Raw264.7 cells,the OD-micelle/Cur suppressed the inflammatory response,decreased TNF-αand IL-6 levels,and improved lung histopathology.The antisense oligoDNA corona contributed to the efficacy through miR-155 inhibition,which was confirmed by comparison with scrambled OD-micelle/Cur and increased SOCS1 expression in lung tissue.Furthermore,RAGE pathway inhibition attenuated the inflammatory response,suggesting that RAGE signaling could be an additional therapeuticmechanism.Therefore,OD-micelles are a systemically administrable,lung-targeted oligonucleotide nanoplatform with dualmechanism anti-inflammatory activity for the treatment of ALI.展开更多
Objectives:Early detection of hepatocellular carcinoma(HCC)is a significant challenge due to the limited sensitivity of alpha-fetoprotein(AFP).This study aimed to assess serum-derived extracellular vesicleencapsulated...Objectives:Early detection of hepatocellular carcinoma(HCC)is a significant challenge due to the limited sensitivity of alpha-fetoprotein(AFP).This study aimed to assess serum-derived extracellular vesicleencapsulated GULP PTB domain-containing engulfment adaptor 1(EV-GULP1)as a novel,noninvasive biomarker for HCC detection and prognosis,leveraging the potential of tumor-specific molecules carried by small extracellular vesicles(EVs).Methods:The study utilized both internal and external cohorts of HCC patients and controls.Small EVs were isolated from serum samples,then characterized and validated to confirm their identity.The expression levels of EV-GULP1 were quantified using quantitative reverse transcription polymerase chain reaction(qRT-PCR).Results:EVGULP1 expression was found to be significantly higher in HCC patients,including those with early-stage disease,when compared to control groups.It demonstrated superior diagnostic accuracy over AFP,achieving an area under the curve(AUC)of 0.919,and was particularly effective in detecting AFP-negative cases.Furthermore,high EV-GULP1 expression correlated with worse overall and disease-free survival outcomes.Conclusion:These findings highlight EV-GULP1 as a highly promising noninvasive biomarker for hepatocellular carcinoma.It offers improved diagnostic accuracy for early detection and better risk stratification for prognosis compared to the current standard,AFP.展开更多
Herpes simplex virus thymidine kinase(HSVtk)gene therapy is a promising strategy for glioblastoma therapy.However,delivery of plasmid DNA(pDNA)encoding HSVtk into the brain by systemic administration is a challenge si...Herpes simplex virus thymidine kinase(HSVtk)gene therapy is a promising strategy for glioblastoma therapy.However,delivery of plasmid DNA(pDNA)encoding HSVtk into the brain by systemic administration is a challenge since pDNA can hardly penetrate the bloodbrain barrier.In this study,an exosome-membrane(EM)and polymer-based hybrid complex was developed for systemic delivery of pDNA into the brain.Histidine/arginine-linked polyamidoamine(PHR)was used as a carrier.PHR binds to pDNA by electrostatic interaction.The pDNA/PHR complex was mixed with EM and subjected to extrusion to produce pDNA/PHR-EM hybrid complex.For glioblastoma targeting,T7 peptide was attached to the pDNA/PHR-EM complex.Both pDNA/PHR-EM and T7-decorated pDNA/PHR-EM(pDNA/PHREM-T7)had a surface charge of–5 mV and a size of 280 nm.Transfection assays indicated that pDNA/PHR-EM-T7 enhanced the transfection to C6 cells compared with pDNA/PHREM.Intravenous administration of pHSVtk/PHR-EM-T7 showed that pHSVtk/PHR-EM and pHSVtk/PHR-EM-T7 delivered pHSVtk more efficiently than pHSVtk/lipofectamine and pHSVtk/PHR into glioblastoma in vivo.pHSVtk/PHR-EM-T7 had higher delivery efficiency than pHSVtk/PHR-EM.As a result,the HSVtk expression and apoptosis levels in the tumors of the pHSVtk/PHR-EM-T7 group were higher than those of the other control groups.Therefore,the pDNA/PHR-EM-T7 hybrid complex is a useful carrier for systemic delivery of pHSVtk to glioblastoma.展开更多
Cu catalysts can convert CO2 through an electrochemical reduction reaction into a variety of useful carbon-based products.However,this capability provides an obstacle to increasing the selectivity for a single prod...Cu catalysts can convert CO2 through an electrochemical reduction reaction into a variety of useful carbon-based products.However,this capability provides an obstacle to increasing the selectivity for a single product.Herein,we report a simple fabrication method for a Cu-Pd alloy catalyst for use in a membrane electrode assembly(MEA)-based CO2 electrolyzer for the electrochemical CO2 reduction reaction(ECRR)with high selectivity for CO production.When the composition of the Cu-Pd alloy catalyst was fabricated at 6:4,the selectivity for CO increased and the production of multi-carbon compounds and hydrogen is suppressed.Introducing a Cu-Pd alloy catalyst with 6:4 ratio as the cathode of the MEAbased CO2 electrolyzer showed a CO faradaic efficiency of 92.8%at 2.4 Vcell.We assumed that these results contributed from the crystal planes on the surface of the Cu-Pd alloy.The phases of the Cu-Pd alloy catalyst were partially separated through annealing to fabricate a catalyst with high selectivity for CO at low voltage and C2H_4 at high voltage.The results of CO-stripping testing confirmed that when Cu partially separates from the lattice of the Cu-Pd alloy,the desorption of~*CO is suppressed,suggesting that C-C coupling reaction is favored.展开更多
Background: Over 400 genes contribute to the development of congenital heart disease (CHD). Additionally,multisystemic manifestations accompanying syndromic CHD pose a higher risk of genetic diseases. This studyinvest...Background: Over 400 genes contribute to the development of congenital heart disease (CHD). Additionally,multisystemic manifestations accompanying syndromic CHD pose a higher risk of genetic diseases. This studyinvestigated the diagnostic yield of whole-exome sequencing (WES) in patients with sporadic syndromic CHDand the phenotypic factors affecting the genetic diagnostic rate. Methods: Sixty-four patients with sporadic syndromicCHD aged 0.05), betweenthe groups with and without a diagnostic variant. However, patients with ≥3 extracardiac phenotypes had a significantlyhigher likelihood of having a diagnostic variant than those with ≤2 (38.3% vs. 5.9%, odds ratio = 9.93,95% confidence interval = 1.21–81.44, P = 0.013). Conclusions: The number of extracardiac phenotypes is importantin predicting the possibility of genetic diagnosis. Physicians will be able to select patients with a high probabilityof genetic diagnosis and provide appropriate genetic counseling based on the results of this study.展开更多
Background and Method:The genetic cause of infantile-onset cardiomyopathy is rarely investigated.Here,we conducted whole exome sequencing(WES)and mitochondrial DNA(mtDNA)sequencing in eight patients with infantile-ons...Background and Method:The genetic cause of infantile-onset cardiomyopathy is rarely investigated.Here,we conducted whole exome sequencing(WES)and mitochondrial DNA(mtDNA)sequencing in eight patients with infantile-onset cardiomyopathy to identify genetic variations.Result:Among these patients,two(25%)had dilated cardiomyopathy(DCMP),two(25%)had left ventricular non-compaction(LVNC),and four(50%)had hypertrophic cardiomyopathy(HCMP).Except four patients identified prenatally,the remaining patients presented at a median age of 85.5 days.WES identified genetic variants in a total of seven(87.5%)patients and mtDNA sequencing in the other case.TPM1 and MYH7 variants were identified in the two patients with DCMP;MYH11 and MYLK2 variants in the two patients with LVNC;HRAS,BRAF,and MYH7 variants in three patients with HCMP;and MT-ND1 variant in one patient with HCMP having high blood lactic acid levels.Among the eight variants,four were classified as pathogenic or likely-pathogenic according to the American College of Medical Genetics(ACMG)guidelines,and the remaining were identified as variants of unknown significance(VUSs).Three pathogenic mutations were de novo,whereas four(likely-pathogenic or VUSs)were inherited from a respective parent,excluding one variant where parental testing was unavailable,questioning whether these inherited variants are disease-causing.Three patients died before 3 months of age.Conclusion:Genomic studies,such as WES with additional mtDNA sequencing,can identify a genetic variant in high proportions of patients with infantile-onset cardiomyopathy.The clinical implication of the parentally inherited variant needs to be assessed in a larger patient and family cohort with a longitudinal follow-up.展开更多
Nucleic acid drugs are desirable therapeutics for the treatment of fatal diseases like cancers.For clinical translation of nucleic acid drugs,carrier systems that protect nucleic acid from degradation and help cellula...Nucleic acid drugs are desirable therapeutics for the treatment of fatal diseases like cancers.For clinical translation of nucleic acid drugs,carrier systems that protect nucleic acid from degradation and help cellular uptake are needed.Accordingly cationic polymers are used as a carrier due to their strong electrostatic interaction with nucleic acids,which produce nanosized particles[1].展开更多
Origami structures provide functional advantages to rigid electronics through geometric transformations.However,the transformations involved in folding and deployment cause stress concentration on flexure hinges of or...Origami structures provide functional advantages to rigid electronics through geometric transformations.However,the transformations involved in folding and deployment cause stress concentration on flexure hinges of origami structure,triggering electronic malfunction.Here,we report origami electronics based on a fiber-reinforced electronic composite.A thin PEDOT:PSS-based electronic composite minimizes stress during folding without electrode damage.Nylon is embedded in this foldable composite and,despite being thin and flexible for folding,provides high tensile resistance to prevent plastic deformation and tearing under tension.This strategy enables the creation of flexure hinges for origami electronics that maintain mechanical and electrical stability under repeated transformations.Origami electronics that integrate the high-durability composite can be used in display applications supporting 25-fold compression with the Flasher origami structure and 2D-to-3D deployment with the Kresling origami structure.The ability of origami electronics to withstand bending and tensile stress enables shape-reconfigurable displays requiring repeated reconfiguration across multiple hinges.展开更多
Acute lung injury(ALI)is a devastating inflammatory disease.MicroRNA155(miR155)in alveolar macrophages and lung epithelial cells enhances inflammatory reactions by inhibiting the suppressor of cytokine signaling 1(SOC...Acute lung injury(ALI)is a devastating inflammatory disease.MicroRNA155(miR155)in alveolar macrophages and lung epithelial cells enhances inflammatory reactions by inhibiting the suppressor of cytokine signaling 1(SOCS1)in ALI.Anti-miR155 oligonucleotide(AMO155)have been suggested as a potential therapeutic reagent for ALI.However,a safe and efficient carrier is required for delivery of AMO155 into the lungs for ALI therapy.In this study,cell membrane-derived nanovesicles(CMNVs)were produced from cell membranes of LA4 mouse lung epithelial cells and evaluated as a carrier of AMO155 into the lungs.For preparation of CMNVs,cell membranes were isolated from LA4 cells and CMNVs were produced by extrusion.Cholesterol-conjugated AMO155(AMO155c)was loaded into CMNVs and extracellular vesicles(EVs)by sonication.The physical characterization indicated that CMNVs with AMO155c(AMO155c/CMNV)were membrane-structured vesicles with a size of�120nm.The delivery efficiency and therapeutic efficacy of CMNVs were compared with those of EVs or polyethylenimine(25kDa,PEI25k).The delivery efficiency of AMO155c by CMNVs was similar to that by EVs.As a result,the miR155 levels were reduced by AMO155c/CMNV and AMO155c/EV.AMO155c/CMNV were administered intratracheally into the ALI models.The SOCS1 levels were increased more efficiently by AMO155c/CMNV than by the others,suggesting that miR155 effectively was inhibited by AMO155c/CMNV.In addition,the inflammatory cytokines were reduced more effectively by AMO155c/CMNV than they were by AMO155c/EV and AMO155c/PEI25k,reducing inflammation reactions.The results suggest that CMNVs are a useful carrier of AMO155c in the treatment of ALI.展开更多
Bioelectronic implants in the deep brain provide the opportunity to monitor deep brain activity with potential applications in disease diagnostics and treatment.However,mechanical mismatch between a probe and brain ti...Bioelectronic implants in the deep brain provide the opportunity to monitor deep brain activity with potential applications in disease diagnostics and treatment.However,mechanical mismatch between a probe and brain tissue can cause surgical trauma in the brain and limit chronic probe-based monitoring,leading to performance degradation.Here,we report a transient shuttle-based probe consisting of a PVA and a mesh-type probe.A rigid shuttle based on PVA implants an ultrathin mesh probe in the target deep brain without a tangle,while creating both a sharp edge for facile penetration into the brain and an anti-friction layer between the probe and brain tissue through dissolving its surface.The capability to shuttle dissolved materials can exclude the retracted process of the shuttle in the brain.Complete dissolution of the shuttle provides a dramatic decrease(~1078-fold)in the stiffness of the probe,which can therefore chronically monitor a wide area of the brain.These results indicate the ability to use a simplistic design for implantation of wide and deep brain probes while preventing unnecessary damage to the brain and probe degradation during long-term use.展开更多
基金supported by the National Research Foundation of Korea(NRF)grant funded by the Korea government(MSIT)(No.2022M3H4A6A0103720142)the National Research Council of Science&Technology(NST)grant by the Korea government(MSIT)(No.GTL24011-000)+1 种基金the Technology Innovation Program(RS-2024-00404165)through the Korea Planning&Evaluation Institute of Industrial Technology(KEIT)funded by the Ministry of Trade,Industry&Energy(MOTIE,Korea)supported by the Samsung SDI Co.Ltd.and the Korea Institute of Science and Technology(KIST)institutional program(2E33942,2E3394B)。
摘要Strategies for achieving high-energy-density lithium-ion batteries include using high-capacity materials such as high-nickel NCM,increasing the active material content in the electrode by utilizing high-conductivity carbon nanotubes(CNT)conductive materials,and electrode thickening.However,these methods are still limited due to the limitation in the capacity of high-nickel NCM,aggregation of CNT conductive materials,and nonuniform material distribution of thick-film electrodes,which ultimately damage the mechanical and electrical integrity of the electrode,leading to a decrease in electrochemical performance.Here,we present an integrated binder-CNT composite dispersion solution to realize a high-solids-content(>77 wt%)slurry for high-mass-loading electrodes and to mitigate the migration of binder and conductive additives.Indeed,the approach reduces solvent usage by approximately 30%and ensures uniform conductive additive-binder domain distribution during electrode manufacturing,resulting in improved coating quality and adhesive strength for high-mass-loading electrodes(>12 mAh cm−2).In terms of various electrode properties,the presented electrode showed low resistance and excellent electrochemical properties despite the low CNT contents of 0.6 wt%compared to the pristine-applied electrode with 0.85 wt%CNT contents.Moreover,our strategy enables faster drying,which increases the coating speed,thereby offering potential energy savings and supporting carbon neutrality in wet-based electrode manufacturing processes.
基金supported by the Individual Basic Science&Engineering Research Program(NRF-2022R1A2B5B01001920 and RS-2026-25473739)through the National Research Foundation,funded by the Ministry of Science and ICT in Korea.
摘要Antisense oligonucleotides offer a powerful strategy for suppressing pro-inflammatory microRNAs,but efficient long-term delivery after systemic administration remains challenging.In this study,we developed a self-assembling oligoDNA-nanomicelle(ODmicelle)platform to simultaneously deliver antisense oligoDNA targeting miR-155 and curcumin,a hydrophobic anti-inflammatory agent,to the lung.The curcumin formulation(OD-micelle/Cur)can be administered intravenously and has a negatively charged surface and average particle size of∼160 nm,supporting scavenger receptor(SR)-mediated pulmonary delivery.Fluorescence imaging and flow cytometry analyses demonstrated that cellular uptake was comparable to that of OD-micelle/PEI25k,a widely used cationic carrier standard.Hemocompatibility tests demonstrated reduced red blood cell aggregation,compared with PEI25k,indicating improved hemocompatibility without compromising delivery efficiency.Mechanistic studies supported the receptor-dependent transport of the oligoDNA corona.Pre-treatment with excess oligonucleotides reduced the cellular uptake and in vivo lung accumulation of Cy5-labeled OD-micelle/Cur.Furthermore,a RAGE antagonist peptide similarly reduced cellular uptake,suggesting the involvement of RAGE in the SR pathway.In LPS-induced acute lung injury(ALI)mice and LPSstimulated Raw264.7 cells,the OD-micelle/Cur suppressed the inflammatory response,decreased TNF-αand IL-6 levels,and improved lung histopathology.The antisense oligoDNA corona contributed to the efficacy through miR-155 inhibition,which was confirmed by comparison with scrambled OD-micelle/Cur and increased SOCS1 expression in lung tissue.Furthermore,RAGE pathway inhibition attenuated the inflammatory response,suggesting that RAGE signaling could be an additional therapeuticmechanism.Therefore,OD-micelles are a systemically administrable,lung-targeted oligonucleotide nanoplatform with dualmechanism anti-inflammatory activity for the treatment of ALI.
基金supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare,Republic of Korea(HR21C1003)the Bio and Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science and ICT(RS-2022-NR070489,RS-2023-00210847,RS-2024-00422549,RS-2024-00463331,RS-2025-00521818,and RS-2025-00562556).
摘要Objectives:Early detection of hepatocellular carcinoma(HCC)is a significant challenge due to the limited sensitivity of alpha-fetoprotein(AFP).This study aimed to assess serum-derived extracellular vesicleencapsulated GULP PTB domain-containing engulfment adaptor 1(EV-GULP1)as a novel,noninvasive biomarker for HCC detection and prognosis,leveraging the potential of tumor-specific molecules carried by small extracellular vesicles(EVs).Methods:The study utilized both internal and external cohorts of HCC patients and controls.Small EVs were isolated from serum samples,then characterized and validated to confirm their identity.The expression levels of EV-GULP1 were quantified using quantitative reverse transcription polymerase chain reaction(qRT-PCR).Results:EVGULP1 expression was found to be significantly higher in HCC patients,including those with early-stage disease,when compared to control groups.It demonstrated superior diagnostic accuracy over AFP,achieving an area under the curve(AUC)of 0.919,and was particularly effective in detecting AFP-negative cases.Furthermore,high EV-GULP1 expression correlated with worse overall and disease-free survival outcomes.Conclusion:These findings highlight EV-GULP1 as a highly promising noninvasive biomarker for hepatocellular carcinoma.It offers improved diagnostic accuracy for early detection and better risk stratification for prognosis compared to the current standard,AFP.
基金supported by the Individual Basic Science&Engineering Research Program(NRF-2022R1A2B5B01001920)through the National Research Foundation,funded by the Ministry of Science and ICT in Korea.
摘要Herpes simplex virus thymidine kinase(HSVtk)gene therapy is a promising strategy for glioblastoma therapy.However,delivery of plasmid DNA(pDNA)encoding HSVtk into the brain by systemic administration is a challenge since pDNA can hardly penetrate the bloodbrain barrier.In this study,an exosome-membrane(EM)and polymer-based hybrid complex was developed for systemic delivery of pDNA into the brain.Histidine/arginine-linked polyamidoamine(PHR)was used as a carrier.PHR binds to pDNA by electrostatic interaction.The pDNA/PHR complex was mixed with EM and subjected to extrusion to produce pDNA/PHR-EM hybrid complex.For glioblastoma targeting,T7 peptide was attached to the pDNA/PHR-EM complex.Both pDNA/PHR-EM and T7-decorated pDNA/PHR-EM(pDNA/PHREM-T7)had a surface charge of–5 mV and a size of 280 nm.Transfection assays indicated that pDNA/PHR-EM-T7 enhanced the transfection to C6 cells compared with pDNA/PHREM.Intravenous administration of pHSVtk/PHR-EM-T7 showed that pHSVtk/PHR-EM and pHSVtk/PHR-EM-T7 delivered pHSVtk more efficiently than pHSVtk/lipofectamine and pHSVtk/PHR into glioblastoma in vivo.pHSVtk/PHR-EM-T7 had higher delivery efficiency than pHSVtk/PHR-EM.As a result,the HSVtk expression and apoptosis levels in the tumors of the pHSVtk/PHR-EM-T7 group were higher than those of the other control groups.Therefore,the pDNA/PHR-EM-T7 hybrid complex is a useful carrier for systemic delivery of pHSVtk to glioblastoma.
基金supported by the National Research Foundation of Korea(NRF)grant funded by the Korean government MSIT(2021R1A2C2093358,2021R1A4A3027878,2022M3I3A1081901)financial support from the Lotte Chemical Company。
摘要Cu catalysts can convert CO2 through an electrochemical reduction reaction into a variety of useful carbon-based products.However,this capability provides an obstacle to increasing the selectivity for a single product.Herein,we report a simple fabrication method for a Cu-Pd alloy catalyst for use in a membrane electrode assembly(MEA)-based CO2 electrolyzer for the electrochemical CO2 reduction reaction(ECRR)with high selectivity for CO production.When the composition of the Cu-Pd alloy catalyst was fabricated at 6:4,the selectivity for CO increased and the production of multi-carbon compounds and hydrogen is suppressed.Introducing a Cu-Pd alloy catalyst with 6:4 ratio as the cathode of the MEAbased CO2 electrolyzer showed a CO faradaic efficiency of 92.8%at 2.4 Vcell.We assumed that these results contributed from the crystal planes on the surface of the Cu-Pd alloy.The phases of the Cu-Pd alloy catalyst were partially separated through annealing to fabricate a catalyst with high selectivity for CO at low voltage and C2H_4 at high voltage.The results of CO-stripping testing confirmed that when Cu partially separates from the lattice of the Cu-Pd alloy,the desorption of~*CO is suppressed,suggesting that C-C coupling reaction is favored.
基金This work was supported by an Institute for Information and CommunicationsTechnology Promotion (IITP) grant funded by the Korean Government (MSIT) (2018-0-00861,Intelligent SW Technology Development for Medical Data Analysis).
摘要Background: Over 400 genes contribute to the development of congenital heart disease (CHD). Additionally,multisystemic manifestations accompanying syndromic CHD pose a higher risk of genetic diseases. This studyinvestigated the diagnostic yield of whole-exome sequencing (WES) in patients with sporadic syndromic CHDand the phenotypic factors affecting the genetic diagnostic rate. Methods: Sixty-four patients with sporadic syndromicCHD aged 0.05), betweenthe groups with and without a diagnostic variant. However, patients with ≥3 extracardiac phenotypes had a significantlyhigher likelihood of having a diagnostic variant than those with ≤2 (38.3% vs. 5.9%, odds ratio = 9.93,95% confidence interval = 1.21–81.44, P = 0.013). Conclusions: The number of extracardiac phenotypes is importantin predicting the possibility of genetic diagnosis. Physicians will be able to select patients with a high probabilityof genetic diagnosis and provide appropriate genetic counseling based on the results of this study.
基金This work was supported by an Institute for Information and Communications Technology Promotion(IITP)grant funded by the Korean government(MSIT)(2018-0-00861,Intelligent SW Technology Development for Medical Data Analysis).
摘要Background and Method:The genetic cause of infantile-onset cardiomyopathy is rarely investigated.Here,we conducted whole exome sequencing(WES)and mitochondrial DNA(mtDNA)sequencing in eight patients with infantile-onset cardiomyopathy to identify genetic variations.Result:Among these patients,two(25%)had dilated cardiomyopathy(DCMP),two(25%)had left ventricular non-compaction(LVNC),and four(50%)had hypertrophic cardiomyopathy(HCMP).Except four patients identified prenatally,the remaining patients presented at a median age of 85.5 days.WES identified genetic variants in a total of seven(87.5%)patients and mtDNA sequencing in the other case.TPM1 and MYH7 variants were identified in the two patients with DCMP;MYH11 and MYLK2 variants in the two patients with LVNC;HRAS,BRAF,and MYH7 variants in three patients with HCMP;and MT-ND1 variant in one patient with HCMP having high blood lactic acid levels.Among the eight variants,four were classified as pathogenic or likely-pathogenic according to the American College of Medical Genetics(ACMG)guidelines,and the remaining were identified as variants of unknown significance(VUSs).Three pathogenic mutations were de novo,whereas four(likely-pathogenic or VUSs)were inherited from a respective parent,excluding one variant where parental testing was unavailable,questioning whether these inherited variants are disease-causing.Three patients died before 3 months of age.Conclusion:Genomic studies,such as WES with additional mtDNA sequencing,can identify a genetic variant in high proportions of patients with infantile-onset cardiomyopathy.The clinical implication of the parentally inherited variant needs to be assessed in a larger patient and family cohort with a longitudinal follow-up.
摘要Nucleic acid drugs are desirable therapeutics for the treatment of fatal diseases like cancers.For clinical translation of nucleic acid drugs,carrier systems that protect nucleic acid from degradation and help cellular uptake are needed.Accordingly cationic polymers are used as a carrier due to their strong electrostatic interaction with nucleic acids,which produce nanosized particles[1].
基金support from the Ajou University research fundsupported by funding from the NRF of Korea(grant nos.RS-2023-00277110,RS-2023-00271830,RS-2024-00403639,RS-2024-00466111,and RS-2024-00411660)supported by Samsung Display(grant number:S-2025-C1462-00002).
摘要Origami structures provide functional advantages to rigid electronics through geometric transformations.However,the transformations involved in folding and deployment cause stress concentration on flexure hinges of origami structure,triggering electronic malfunction.Here,we report origami electronics based on a fiber-reinforced electronic composite.A thin PEDOT:PSS-based electronic composite minimizes stress during folding without electrode damage.Nylon is embedded in this foldable composite and,despite being thin and flexible for folding,provides high tensile resistance to prevent plastic deformation and tearing under tension.This strategy enables the creation of flexure hinges for origami electronics that maintain mechanical and electrical stability under repeated transformations.Origami electronics that integrate the high-durability composite can be used in display applications supporting 25-fold compression with the Flasher origami structure and 2D-to-3D deployment with the Kresling origami structure.The ability of origami electronics to withstand bending and tensile stress enables shape-reconfigurable displays requiring repeated reconfiguration across multiple hinges.
基金supported by the Basic Science&Engineering Research Program(NRF-2022R1A2B5B01001920)the National Research Foundation,funded by the Ministry of Science and ICT in Korea.
摘要Acute lung injury(ALI)is a devastating inflammatory disease.MicroRNA155(miR155)in alveolar macrophages and lung epithelial cells enhances inflammatory reactions by inhibiting the suppressor of cytokine signaling 1(SOCS1)in ALI.Anti-miR155 oligonucleotide(AMO155)have been suggested as a potential therapeutic reagent for ALI.However,a safe and efficient carrier is required for delivery of AMO155 into the lungs for ALI therapy.In this study,cell membrane-derived nanovesicles(CMNVs)were produced from cell membranes of LA4 mouse lung epithelial cells and evaluated as a carrier of AMO155 into the lungs.For preparation of CMNVs,cell membranes were isolated from LA4 cells and CMNVs were produced by extrusion.Cholesterol-conjugated AMO155(AMO155c)was loaded into CMNVs and extracellular vesicles(EVs)by sonication.The physical characterization indicated that CMNVs with AMO155c(AMO155c/CMNV)were membrane-structured vesicles with a size of�120nm.The delivery efficiency and therapeutic efficacy of CMNVs were compared with those of EVs or polyethylenimine(25kDa,PEI25k).The delivery efficiency of AMO155c by CMNVs was similar to that by EVs.As a result,the miR155 levels were reduced by AMO155c/CMNV and AMO155c/EV.AMO155c/CMNV were administered intratracheally into the ALI models.The SOCS1 levels were increased more efficiently by AMO155c/CMNV than by the others,suggesting that miR155 effectively was inhibited by AMO155c/CMNV.In addition,the inflammatory cytokines were reduced more effectively by AMO155c/CMNV than they were by AMO155c/EV and AMO155c/PEI25k,reducing inflammation reactions.The results suggest that CMNVs are a useful carrier of AMO155c in the treatment of ALI.
基金supported by funding from the NRF of Korea(grant no.2022R1C1C1005741,2022R1A2C2093100,RS-2023-00217595,RS-2023-00271830)supported by the Korea Environment Industry&Technology Institute(KEITI)through the Digital Infrastructure Building Project for Monitoring,Surveying,and Evaluating the Environmental Health Program,funded by the Korea Ministry of Environment(MOE)(2021003330009).
摘要Bioelectronic implants in the deep brain provide the opportunity to monitor deep brain activity with potential applications in disease diagnostics and treatment.However,mechanical mismatch between a probe and brain tissue can cause surgical trauma in the brain and limit chronic probe-based monitoring,leading to performance degradation.Here,we report a transient shuttle-based probe consisting of a PVA and a mesh-type probe.A rigid shuttle based on PVA implants an ultrathin mesh probe in the target deep brain without a tangle,while creating both a sharp edge for facile penetration into the brain and an anti-friction layer between the probe and brain tissue through dissolving its surface.The capability to shuttle dissolved materials can exclude the retracted process of the shuttle in the brain.Complete dissolution of the shuttle provides a dramatic decrease(~1078-fold)in the stiffness of the probe,which can therefore chronically monitor a wide area of the brain.These results indicate the ability to use a simplistic design for implantation of wide and deep brain probes while preventing unnecessary damage to the brain and probe degradation during long-term use.